PCT of Pharmacopuncture Therapy for Chronic Low Back Pain : A Pilot Study
CompletedNot applicableNCT04576520
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
This is pilot study for a 2-arm parallel pragmatic randomized controlled trial that will compare pharmacopuncture therapy and physical therapy for chronic low back pain.
Study details
- Official title
- Pragmatic Randomized Controlled Trial of Pharmacopuncture Therapy for Chronic Low Back Pain : A Pilot Study
- Conditions
- Interventions
- Procedure: pharmacopuncture therapy
- Procedure: physical therapy
- Sponsor
- Jaseng Medical Foundation
- Start date
- 2020-10-13
- Primary completion
- 2021-03-26
- Sex
- All
- Age range
- from 19 Years to 70 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- South Korea
- Total sites listed
- 4
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. low back pain for more than 6 months 2. Visual Analogue Scale (VAS) of low back pain is more than 5 3. 19-70 years old 4. participants who agreed and wrote informed consents Exclusion Criteria: 1. Migration of cancer reaching to spine, fracture of spine 2. Progressive neurologic deficits or severe neurologic deficits 3. Cancer, fibromyalgia, RA, or goat 4. Stroke, MI, kidney disease, dimentia, diabetic neuropathy, or epilepsy 5. Participants taking steroid, immunosuppressant, or psychotropic medication 6. Hemorrhagic disease, severe diabetes or taking anticoagulant drug 7. Participants who took NSAIDs or pharmacopuncture within 1 week 8. Pregnant or lactating women 9. Participants who had undergone cervical surgery within 3 months 10. Participants who had participated in other clinical trial within 1 month, or have plan for participation in other trial during follow up period of this trial 11. Participants who can not write informed consent 12. Participants who is difficult to participate in the trial according to investigator's decision
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT04576520